TRIDENT LIFELINE
Back to All Ratios
|
TRIDENT LIFELINE Last 5 Year Fixed Capital/Sales History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
Fixed Capital/Sales(x) | 0.31 | 0.10 | 0.10 |
What is the latest Fixed Capital/Sales ratio of TRIDENT LIFELINE ?
Year | Fixed Capital/Sales |
---|---|
Mar2024 | 0.31 |
Mar2023 | 0.10 |
Mar2022 | 0.10 |
How is Fixed Capital/Sales of TRIDENT LIFELINE Trending?
Years | Fixed Capital/Sales | % Change | |
---|---|---|---|
Mar2024 | 0.31 | 210.00 | |
Mar2023 | 0.1 | 0.00 | |
Mar2022 | 0.1 | - |
Other Financial Ratios of TRIDENT LIFELINE
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Fixed Capital/Sales ratio of peers of TRIDENT LIFELINE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TRIDENT LIFELINE | ₹286.9 Cr | 4.9% | -4.9% | 33.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,213.0 Cr | 4.7% | -5.4% | 0.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,403.0 Cr | 0.5% | -9.8% | 55.5% | Stock Analytics | |
CIPLA | ₹117,415.0 Cr | 2% | -1.8% | -1.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹104,791.0 Cr | 2.6% | -6.1% | 14% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,228.2 Cr | -0.9% | -10% | -11.3% | Stock Analytics |
TRIDENT LIFELINE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TRIDENT LIFELINE | 4.9% |
-4.9% |
33.5% |
SENSEX | 1.5% |
-5.1% |
0.6% |
You may also like the below Video Courses